Chemists facing problem of plenty as demand for antiviral drugs falls
Updated:
Updated:
Share Article
Stocks of Remdesivir have a short shelf life of three months.
| Photo Credit:
File Photo Following a decline in COVID-19 cases in the country, chemists who had stocked up on antiviral drugs Remdesivir and Favipiravir used in the treatment of moderate and severe cases of the disease are facing a problem of plenty.
With the stocks having a short shelf life of three months, most of the products are nearing expiry. As the chemists had procured these drugs on advance payments, they are worried of suffering losses, with pharma companies not accepting the stocks back.